Mobia Medical is a commercial-stage medical device company focused on stroke rehabilitation. Its flagship Vivistim Paired VNS System pairs implanted vagus nerve stimulation with physical therapy to promote neuroplasticity and improve upper-limb function in chronic ischemic stroke survivors with moderate to severe impairment. It is positioned as an FDA-approved option for this niche and is sold mainly to U.S. stroke and rehabilitation centers.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q1 2025 | 5.7 | — | -10.7 | — |
| Q2 2025 | 6.7 | — | -10.5 | — |
| Q1 2026 | 12.1 | 113.3% | -17.7 | — |
| Q2 2026 | 13.5 | 102.3% | -21 | — |
All markets — KeepWinning global stock screener
Other companies on Nasdaq: LCNB Corp. (LCNB), Xunlei Limited (XNET), Alto Ingredients, Inc. (ALTO), Anika Therapeutics, Inc. (ANIK), First National Corporation (FXNC), Karman Line Acquisition Corp. (XTER)